Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OPTIRAY safely and effectively. See full prescribing information for OPTIRAY.OPTIRAYTM (ioversol) injection, for intra-arterial or intra-venous useInitial U.S. Approval: 1988
Medication labelWhy this: Advisory · dailymed-prescription
OPTIRAY is indicated for: In adults OPTIRAY 300: cerebral arteriography and peripheral arteriography. OPTIRAY 320: cerebral arteriography, peripheral arteriography, visceral and renal arteriography, aortography, coronary arteriography, and left ventriculography. OPTIRAY 350: peripheral arteriography coronary arteriography, and left ventriculography. In pediatric patients OPTIRAY 320 and OPTIRAY 350: angiocardiography. In adults OPTIRAY 300: CT imaging of the head and body, venography, and intravenous excretory urography. OPTIRAY 320: CT imaging of the head and body, venography, and intravenous excretory urography. OPTIRAY 350: CT imaging of the head and body, venography, intravenous excretory urography, and intravenous digital subtraction angiography (IV-DSA). In pediatric patients OPTIRAY 320: CT imaging of the head and body, and intravenous excretory urography.
- generic_name
- ioversol
- product_names
- Ioversol
- ndc
- 0019-1333, 0019-1323, 0019-1332, 0019-1333-06, 0019-1333-11, 0019-1333-16, 0019-1333-21, 0019-1333-75, 0019-1333-77, 0019-1333-91, 0019-1333-83, 0019-1333-81, 0019-1333-78, 0019-1333-52, 0019-1333-95, 0019-1333-90, 0019-1333-87, 0019-1333-55, 0019-1333-85, 0019-1333-00, 0019-1333-27, 0019-1323-06, 0019-1323-11, 0019-1323-16, 0019-1323-21, 0019-1323-73, 0019-1323-75, 0019-1323-77, 0019-1323-91, 0019-1323-83, 0019-1323-81, 0019-1323-70, 0019-1323-78, 0019-1323-52, 0019-1323-95, 0019-1323-90, 0019-1323-87, 0019-1323-55, 0019-1323-85, 0019-1323-00, 0019-1323-27, 0019-1323-02, 0019-1323-04, 0019-1332-06, 0019-1332-11, 0019-1332-16, 0019-1332-21, 0019-1332-75, 0019-1332-78, 0019-1332-91, 0019-1332-83, 0019-1332-90, 0019-1332-00
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en